8/21/2019 Sosialisasi Pentabio Blitar 2013
1/39
Terobosan baru
!"#$ &$'(") *$+$# ($,- (-),"'$)
8/21/2019 Sosialisasi Pentabio Blitar 2013
2/39
!"#$%&'()*+,-/+01*1+(& !"#$"%&%!"#$&()* +),*"-)
!2"3*#+/+,- *&*(%+!"#$"%&%0&%$(4+**&*(%,3
5"#/&*&22( 0*,33+3!"#$"%&% !"#$&()*%&*.( !"-*./)/
6+#,3 7&0(*+*+3 580&%$&'(' 0&%$(4+*1&0(*+*+3
7(&-"01+2,3 +%92,&%:(&*$!" 0 !"#$"%&%%&(*"-"1)&2!#".13#)&2 1"#)#4)*)/
8/21/2019 Sosialisasi Pentabio Blitar 2013
3/39
!"#$%&'()*+ (-.)*#-/"#
0&/)5 (3(3)+ !"#+"(
6"-+)-) +&-) 7 *)!"8
93#*$!"&%5"6$!"&%5" : *)!" &;,"#.5&- 5"?&* .+&-&
8/21/2019 Sosialisasi Pentabio Blitar 2013
4/39
0#-1"2(3 1"-4 5"&"3 5(3($6*)2"-
@#,"(/) !"-#&!&/!"#$%&"'(
A!)453*)*)/0-3#()*)/ (-3#)/
B)#./)*)/
C*)*)/ 1"+)&
B"!*)( &-*-)*)/)#"'"*'+',
8/21/2019 Sosialisasi Pentabio Blitar 2013
5/39
0#-5"'*)*"- 7
D&*& (& ("1&*) %&5)*& :EF0
8/21/2019 Sosialisasi Pentabio Blitar 2013
6/39
0#-1#6"6 2#$"3("- 6"1(
89:;
:8
?8:==
!"# %&'' ()*+, -./0123+2 4%%56
5("@#
&-#*$%-("
$#-(-4(3(+
)"(--1"
8/21/2019 Sosialisasi Pentabio Blitar 2013
7/39
0@%.() "-42" 2#$"3("-!(6 5( +#)*@*'
5*-(" AB!C: E
G S.*& (&/./!"#$&()*/"-)./
GTUVKKK("1&*)&( !"-*&=.#
-./ 1223
8/21/2019 Sosialisasi Pentabio Blitar 2013
8/39
0@%.() (-+(5#-+(!(6 5( +#)*@*' 5*-("
AB!C: E
8/21/2019 Sosialisasi Pentabio Blitar 2013
9/39
PneumoniaPneumonia merupakan pembunuh no.2 balita
di Indonesia berdasarkan Riskesdas 2007 3
1/3 etiologi pneumonia disebabkan oleh
bakteri Hib 4,5
(3) Indonesia Health Profile.Ministry of Health. 2011:71
(4) Shann F. Etiology of severe pneumonia in children in developing countries. Pediatr Infect Dis. 1986 Mar-Apr;5(2):247-52.
27% Pneumonia caused by H.influenza type B
(5) Sumber: Rudan Igor et.al. Epidemiology and etiology of childhood pneumonia Volume 86, Number 5, May 2008, 321-
416. 10-30% pneumonia disebabkan bakteri Hib
8/21/2019 Sosialisasi Pentabio Blitar 2013
10/39
F#-(-4(3(+W&+ /"5&!.* 3*&(
N"#)#4(&*#$& *"( +) +&5&1 3*&(
D&!&* 1"#)1%.5(F"S
X.1!.=
F"1&*) :+("4( 4#"*&5(+(" Y627 %#"'"**(89
:#"*(" 4#"*&5(+(" (:#;$(+
8/21/2019 Sosialisasi Pentabio Blitar 2013
11/39
G%)*+(H
E+&Z
N"#Q"4&= 5"%)= %&)( +&-)!&+& 1"#43%&*)
[&(/)#&/) \)% D)!"-()-&( +&!&* 1"#Q"4&= ("1&*) LKGVKKK &( !"-
*&=.# : 0"55&4)3 ]=)5+ B.-^)^&5 B*.+$ O-3.!2 XQ"* 7KKGI\0I\)%
]&)-
8/21/2019 Sosialisasi Pentabio Blitar 2013
15/39
8/21/2019 Sosialisasi Pentabio Blitar 2013
16/39
0@#+#-3"+(K(+(2 0@%5*2
8/21/2019 Sosialisasi Pentabio Blitar 2013
17/39
Presentasi depan
8/21/2019 Sosialisasi Pentabio Blitar 2013
18/39
Presentasi belakang
Komposisi vaksin
Saran penyimpanan
8/21/2019 Sosialisasi Pentabio Blitar 2013
19/39
Presentasi vial
Cairan putih
Tutup flip off
Segel alumunium
Label etiket
Blisterplastik
8/21/2019 Sosialisasi Pentabio Blitar 2013
20/39
7K
Vaccine Vial Monitor (VVM) :Jaminan mutu penyimpananvaksin
8/21/2019 Sosialisasi Pentabio Blitar 2013
21/39
1 kotak berisi 10 vial
8/21/2019 Sosialisasi Pentabio Blitar 2013
22/39
Hasil Uji Klinis
8/21/2019 Sosialisasi Pentabio Blitar 2013
23/39
LMNONLPM QRNPM 0SOQPTNC
]5)#)Q&5 D"^"53!1"#* >5
\)% [&QQ)#" ]6
D6>;\0;\)% [&QQ)#" ]6 >=&/" @
D6>;\0;\)% [&QQ)#" ]6 >=&/" @@
D6>;\0;\)% [&QQ)#" ]6 >=&/" @@@
8/21/2019 Sosialisasi Pentabio Blitar 2013
24/39
L)(-(U") Q@(") K)%V L'"@3
Pentavalent
Phase I
Pentavalent
Phase II
Pentavalent
Phase III
Pentavalent
Phase IV
8 $%-3'+ ? $%-3'+ J $%-3'+ = $%-3'+ 9